135 related articles for article (PubMed ID: 10718119)
1. Fenamates and the potent inhibition of human liver phenol sulphotransferase.
Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs.
Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
Eur J Clin Pharmacol; 2000 Apr; 56(1):81-7. PubMed ID: 10853883
[TBL] [Abstract][Full Text] [Related]
3. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
Kankaanranta H; Moilanen E; Vapaatalo H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.
Veronese ME; Burgess W; Zhu X; McManus ME
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):497-502. PubMed ID: 8093002
[TBL] [Abstract][Full Text] [Related]
5. Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid.
Vietri M; Pietrabissa A; Mosca F; Rane A; Pacific GM
Xenobiotica; 2001 Mar; 31(3):153-61. PubMed ID: 11465392
[TBL] [Abstract][Full Text] [Related]
6. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
Gaganis P; Miners JO; Knights KM
Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
[TBL] [Abstract][Full Text] [Related]
7. Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.
Habjan S; Vandenberg RJ
Neurochem Res; 2009 Oct; 34(10):1738-47. PubMed ID: 19444608
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.
Greenwood IA; Large WA
Br J Pharmacol; 1995 Dec; 116(7):2939-48. PubMed ID: 8680728
[TBL] [Abstract][Full Text] [Related]
9. Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.
Sanger GJ; Bennett A
Br J Clin Pharmacol; 1979 Nov; 8(5):479-82. PubMed ID: 508555
[TBL] [Abstract][Full Text] [Related]
10. Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.
Gögelein H; Dahlem D; Englert HC; Lang HJ
FEBS Lett; 1990 Jul; 268(1):79-82. PubMed ID: 1696554
[TBL] [Abstract][Full Text] [Related]
11. The action of flufenamic acid and other nonsteroidal anti-inflammatories on sulfate transport in the isolated perfused rat liver.
Lopez CH; Bracht A; Yamamoto NS; Ishii-Iwamoto EL; Sampaio E; Kelmer-Bracht AM
Gen Pharmacol; 1999 Jun; 32(6):713-20. PubMed ID: 10401997
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by fenamates of calcium influx and proliferation of human lymphocytes.
Kankaanranta H; Luomala M; Kosonen O; Moilanen E
Br J Pharmacol; 1996 Oct; 119(3):487-94. PubMed ID: 8894168
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity.
Chalmers DK; Scholz GH; Topliss DJ; Kolliniatis E; Munro SL; Craik DJ; Iskander MN; Stockigt JR
J Med Chem; 1993 Apr; 36(9):1272-7. PubMed ID: 8487264
[TBL] [Abstract][Full Text] [Related]
14. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. I. Pharmacology.
Winder CV
Ann Phys Med; 1966; Suppl():7-16. PubMed ID: 6004862
[No Abstract] [Full Text] [Related]
15. Effects of the fenamates on the threshold of pain.
Haward LR
Ann Phys Med; 1966; Suppl():55-7. PubMed ID: 4895007
[No Abstract] [Full Text] [Related]
16. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.
Lee YT; Wang Q
Eur J Pharmacol; 1999 Aug; 378(3):349-56. PubMed ID: 10493112
[TBL] [Abstract][Full Text] [Related]
18. Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid.
Keinänen S; Similä S; Kouvalainen K
Eur J Clin Pharmacol; 1978 Jul; 13(5):331-44. PubMed ID: 668793
[TBL] [Abstract][Full Text] [Related]
19. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
Latham BA; Radcliff F; Robinson RG
Ann Phys Med; 1966 Aug; 8(7):242-3. PubMed ID: 5918265
[No Abstract] [Full Text] [Related]
20. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
